SCHEMBL19081790

SCHEMBL19081790

c1ccc2cc3c(cc2c1)oc1c(-c2c4ccccc4c(-c4cccc5ccccc45)c4ccccc24)cc2sc4ccccc4c2c13

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
BRDT Q58F21 1/20 0.33
PSD A5PKW4 1/20 0.33
ESR2 Q92731 3/20 0.32
ELANE P08246 1/20 0.31
SOS1 Q07889 1/20 0.31
PTPN1 P18031 1/20 0.31
ESR1 P03372 2/20 0.31
GPR84 Q9NQS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082048 0.95 BRDT (0.32) BRDTPSDESR2ELANESOS1
SCHEMBL19081777 0.89 ESR2 (0.36) ESR2ELANEPTPN1ESR1
SCHEMBL19082013 0.86 ESR2 (0.34) ESR2ELANEPTPN1ESR1
SCHEMBL19081850 0.85 S1PR5 (0.35) PTPN1GPR84
SCHEMBL27288323 0.83
SCHEMBL17589550 0.81 GPR84 (0.40) PSDESR2SOS1ESR1GPR84
SCHEMBL19082064 0.81 S1PR5 (0.33) BRDTPSDPTPN1
SCHEMBL19081452 0.81 L3MBTL1 (0.36) PSDSOS1
SCHEMBL19082082 0.80
SCHEMBL17944564 0.80 BRDT (0.41) BRDTESR2ELANEESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 BRDT 2777/4885PSD 3197/4885ESR2 542/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 BRDT 2777/4885PSD 3197/4885ESR2 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.